Trial Profile
A Multi-Centre, Open-Label, Non-Controlled Trial on Safety and Efficacy of N8 in Previously Treated Paediatric Patients With Haemophilia A
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Turoctocog alfa (Primary)
- Indications Haemophilia A
- Focus Adverse reactions; Registrational
- Acronyms guardian-3
- Sponsors Novo Nordisk
- 02 Dec 2013 New trial record
- 02 Dec 2013 New trial record